Search Results for 'Drug Development'

Contract Service Directory Companies

View All Buyers Guide Companies »

Contract Service Directory Categories

View All Categories »

• Analytical Services | Biologics, Proteins, Vaccines | Drug Development | Drug Discovery | Laboratory Testing
  

  A Shifting Drug Development Landscape Amid COVID-19 Crisis

  Responding to demand for challenging assays and custom solutions required for complex molecules, biologics, vaccines and other innovative therapies.

  Online Exclusives Kristin Brooks, Contract Pharma 06.22.20
  

  ---

• cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
  

  COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism

  The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.

  Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20
  

  ---

• Drug Development
  

  The Immune System & Drug Development

  Functions, challenges and effective approaches to safety assessment

  Greg Bannish, Vice President, Biopharmaceutical Development, Envigo 05.08.18
  

  ---

• Drug Development
  

  Integrated Early-Stage Drug Development and Manufacturing

  A key to accelerating the drug development process.

  Mark Egerton, Chief Executive Officer, Quotient Sciences 03.09.18
  

  ---

• Clinical Trials | Drug Development | Regulatory Affairs | Toxicology
  

  CRO Industry Update

  Harnessing Data in the Age of Complexity

  Kristin Brooks, Contract Pharma 05.05.16
  

  ---

• Drug Development | Information Technology | Supply Chain | Validation
  

  Agile Drug Development: Lessons from the Software Industry

  Why pharma needs to move from a “waterfall” to a “scrum” model

  Pedram Alaedini, Birnur Ozbas PhD, and Fahri Akdemir, Primapax and C1 Consulting 10.14.14
  

  ---

• Clinical Trials | Drug Development | Laboratory Testing | Risk Management
  

  REMS and Drug Development

  How does the FDA�s risk approach affect new drugs?

  Pablo Garces, MD and Lynda Jacks 01.22.10
  

  ---

• Chemistry | Clinical Trials | Drug Development | Regulatory Affairs | Risk Management | Toxicology | Validation
  

  Optimizing Drug Development Strategies

  Exploring methods to improve the process

  Dr. Kenneth Sokoll 03.02.07
  

  ---